Has Brian Wise, MD received payments from drug or device companies?

Yes. Drug and device makers reported $43,878 in general payments to Brian Wise, MD across 117 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brian Wise, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brian Wise, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brian Wise, MD

Psychiatry · Centennial, CONPI 1043211683

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $38,148 of the $43,878 with a category attached, or 86.9%. 9 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 54.5% of the total. Reporting peaked in 2021 at $25,561 and has fallen 99.4% since, to $147 in 2025. Among psychiatry clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$43,878in general payments, 2019–2025

Across 117 payments — averaging $375.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Supernus Pharmaceuticals, Inc.$24K
AbbVie$11K
Ironshore Pharmaceuticals Inc.$5K
Sunovion Pharmaceuticals Inc.$3K
Alkermes, Inc.$202
E.r. Squibb & Sons, L.L.C.$21
plus $54 from 3 others

What the payments were for

Speaking & faculty fees$38,14887%
Travel & lodging$3,3348%
Food & beverage$2,3895%
Education$70%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Supernus Pharmaceuticals, Inc.	56	$23,930
AbbVie(2 entities)	25	$11,006
Ironshore Pharmaceuticals Inc.	17	$5,224
Sunovion Pharmaceuticals Inc.	10	$3,442
Alkermes, Inc.	5	$202
E.r. Squibb & Sons, L.L.C.	1	$21
Takeda Pharmaceuticals U.S.A., Inc.	1	$19
Otsuka America Pharmaceutical, Inc.	1	$18
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

QELBREE$20,958
VRAYLAR$10,805
Jornay PM 20mg capsules (Bottle of 100)$4,830
LATUDA$3,415
LYBALVI$498

How this compares

$43,878 in reported general payments places this provider in the 95th percentile of 559 psychiatry providers in Colorado.

See all psychiatry providers in Colorado →

Medicare billing

Part B allowed, 2024

$12,542

Medicare patients

Services billed

131

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Lisdexamfetamine Dimesylate	14	$5,421
Oxcarbazepine	24	$1,602
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	19	$997
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	20	$980
Methylphenidate Hcl	13	$581
Dextroamphetamine Sulfate ErDextroamphetamine Sulfate	11	$538
Aripiprazole	21	$528
Risperidone	24	$369
Venlafaxine Hcl ErVenlafaxine Hcl	27	$341
Buspirone Hcl	25	$330
Duloxetine Hcl	19	$318
Trazodone Hcl	42	$285
Bupropion XlBupropion Hcl	15	$257
Prazosin Hcl	11	$255
Clonazepam	27	$249

Paid to pharmacies, not to this prescriber.

Other psychiatry in Centennial

Robert CowanCentennial$29K
Howard EntinCentennial$9K
Thomas VertreesCentennial$3K
John HardyPueblo$828K
Larry SandersLittleton$760K
Jeffrey RichmondDenver$424K
Jennifer FrenchGlendale$115K
Charles ParkLone Tree$89K
Cynthia EppersonAurora$64K
Brenda CzabanDenver$25K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →